Table 2.
Patient | Ocular diagnosis | Age | Sex | Relevant allergies | Symptom onset before use of Restasis | Brief description on disease course | Eye drops in use before start of Restasis |
---|---|---|---|---|---|---|---|
1 | LE VKC | 6 | M | Eczema and asthma | 4 weeks | Presented with persistent epithelial defect and cobblestone giant papillae. Developed shield ulcer complicated by herpes simplex infection; ulcer healed with Restasis and acyclovir ointment with only faint corneal scars. | Patanol/ RT/PF |
| |||||||
2 | BE SAC | 16 | M | Nil | 6 weeks | Left limbitis and BE papillae. Treated with Restasis BD, with recovery of the limbitis and improvement of symptoms. | Patanol/RT/Nadexin |
| |||||||
3 | BE AKC | 10 | M | Eczema and asthma | 2 years | Started Restasis BD with improvement of symptoms. | Patanol/RT/FML |
| |||||||
4 | BE VKC | 13 | M | Allergic rhinitis | 2 years | BE cobblestone giant papillae. Started on Restasis BD then tapered down to once daily on alternate days. | Patanol/ RT/FML/PF |
| |||||||
5 | BE PAC | 12 | F | Nil | 1 year | Improvement in symptoms and decreased punctuate epithelial erosions and reduced conjunctival injection over the papillae with Restasis BD. | Patanol/FML |
| |||||||
6 | BE VKC | 9 | M | Nil | 2 years | On and off limbitis and papillae. Used Restasis BD for 1 year with good control and 1 flare-up requiring QID. Now down to once daily dose on alternate days. | Patanol/RT/FML/PF |
| |||||||
7 | BE AKC | 8 | M | Eczema and asthma | 2 years | BE giant papillae, with reduced conjunctival injection over the papillae Restasis BD | Patanol/RT/Nadexin/Lotemax |
| |||||||
8 | BE VKC | 10 | M | Nil | 1.5 years | Giant papillae, with reduced conjunctival injection over the papillae with Restasis BD. | Patanol/FML |
| |||||||
9 | BE PAC | 14 | M | Asthma | 3 years | Previously started with Restasis BD to TDS. Tapered down to once daily on alternate days after 5 months, with improvement of symptoms. | Patanol Lotemax |
| |||||||
10 | BE PAC | 10 | M | Allergic rhinitis | 3 years | Reduced conjunctival injection over the papillae while on Restasis BD. | Patanol/FML |
| |||||||
11 | BE PAC | 6 | M | Allergic rhinitis | 1 year | Reduced conjunctival injection over the papillae while on Restasis BD. | Patanol |
| |||||||
12 | BE AKC | 16 | M | Allergic rhinitis | 16 months | Papillae with keratitis. Restasis BD used for 4 months, now down to once daily on alternate days, with recovery of the keratitis and improvement of symptoms. | Patanol/RT/FML |
| |||||||
13 | BE PAC | 9 | M | Nil | 4 years | Reduced conjunctival injection over the papillae while on Restasis BD, later stopped due to financial reason. | Patanol/RT FML |
| |||||||
14 | BE VKC | 12 | M | Allergic rhinitis | 2 months | Trantas dots and limbitis with papillae, now on Restasis BD, with recovery of the limbitis and improvement of symptoms. | Patanol/PF |
BE = both eyes.
LE = left eye.
BD = twice daily.
TDS = three times daily.
Patanol = olopatadine hydrochloride ophthalmic solution 0.1%; Alcon Laboratories Inc., Fort Worth, Texas, USA.
RT = Refresh Tears (carboxymethylcellulose sodium 0.5%; Allergan Inc., Irvine, CA, USA).
PF = Pred Forte (prednisolone acetate 1%; Allergan Inc., Irvine, CA USA).
FML = fluorometholone (Allergan Inc., Irvine, CA, USA).
Nadexin = (dexamethasone 0.1% + chloramphenicol 0.5%; National Pharm Co. Ltd., Unit A-D 7/F Candy Novelty House 164 Wai Yip Street, Kowloon, Hong Kong).
Lotemax = (loteprednol etabonate ophthalmic 0.5%; Bausch & Lomb Inc., Tampa, Florida, USA).